MBD2 and prostate adenocarcinoma: m6A is removed by demethylases such as FTO and ALKBH5 [22], whose expression levels were significantly correlated with those of KCNH2 in PRAD, sarcoma (SARC), PAAD, and TGCT (Fig. 4).